ELAN

ELANCO ANIMAL HEALTH INC

ELAN·28414H103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

ELAN (ELANCO ANIMAL HEALTH INC) is held by 206 institutional investors as of Q1 2026. Largest holders: DODGE & COX ($1.6B), FMR LLC ($1.2B), BlackRock, Inc. ($1.1B). Net institutional sentiment: Mixed.

206
Holders
(19 Elite)
$11.2B
Total Value
59% (215)
Consensus
127 buying - 88 selling
13F: Insider & Congress:
ELAN

Smart Money Verdict

View all
Held by 206 funds
19 elite

Who's Trading

ActivistDimensional Fund Advisors LPDimensional Fund Advisors LP5.1%Jul 14, 2026
ActivistDodge & CoxDodge & Cox13.9%May 14, 2026
ActivistPRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/9.2%May 13, 2026
ActivistVAVanguard Capital Management5.3%Apr 29, 2026
ActivistDimensional Fund Advisors LPDimensional Fund Advisors LP4.9%Apr 9, 2026
InsiderKEKurzius Lawrence ErikBuy $213KDec 12, 2025
InsiderSNSimmons Jeffrey NBuy $478KDec 11, 2025
InsiderVMVanHimbergen Robert MBuy $150KDec 11, 2025
InsiderMAModi Rajeev A.Buy $96KDec 11, 2025
CongressValerie HoyleValerie HoyleSale $1,001 - $15,000Sep 23, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
68.9M(-12.8%)$1.6B0.9%
0
Decreased
50.9M(-2.4%)$1.2B0.1%
0
Increased
47.6M(+2.8%)$1.1B0.0%
33
Decreased
45.8M(-0.8%)$1.1B0.9%
0
Decreased
24.5M(-2.2%)$586.9M0.1%
0
New
22.6M$541.7M0.0%
43
New
22.3M$534.5M0.0%
43
Increased
15.3M(+1.9%)$367M0.0%
32
New
13.6M$325.8M1.3%
71
Increased
11.2M(+18.8%)$267.9M0.0%
36
Decreased
8.6M(-1.2%)$205.1M0.0%
0
Increased
8.1M(+70.0%)$194.8M0.0%
45
Decreased
6.4M(-22.6%)$153.6M0.0%
0
Decreased
6.2M(-14.2%)$149.1M0.1%
0
Increased
6M(+4.2%)$143.9M0.5%
38
Increased
5.7M(+737.5%)$135.2M0.1%
58
Decreased
4.6M(-19.2%)$109.6M0.1%
0
Increased
4.4M(+18.6%)$105M0.0%
35
Increased
4.2M(+1.9%)$100.2M0.0%
30
Decreased
3.8M(-2.7%)$91.2M0.0%
0

Showing 1-20 of 223

1 / 12
ELANELANELANCO ANIMAL HEALTH INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used